Use of mometasone furoate for treating upper airway diseases

CAFC
  • US 6,723,713 B2
  • Filed: 04/30/2003
  • Issued: 04/20/2004
  • Est. Priority Date: 01/27/1994
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating allergic rhinitis comprising administering once daily nasal passages 200 micrograms of mometasone furoate.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×